APPLIED GENETIC TECHNOLOGIES CORP 4

4 · APPLIED GENETIC TECHNOLOGIES CORP · Filed Dec 23, 2014

Form 4

Period: 2014-12-22

V.P. & Chief Business Officer

Transactions

Exercise/Conversion
Common Stock
2014-12-22$4.90/sh+9,000$44,100→ 9,000 total
Sale
Common Stock
2014-12-22$20.83/sh−9,000$187,470→ 0 total
Exercise/Conversion
Stock Option (Right to Buy)
2014-12-22−9,000→ 117,968 total
Exercise: $4.90Exp: 2023-09-18→ Common Stock (9,000 underlying)

Footnotes (2)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.6535 to $21.01, inclusive. The reporting person undertakes to provide Applied Genetic Technologies Corporation, any security holder in Applied Genetic Technologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
[F2]The option, representing a right to purchase a total of 126,968 shares, became exercisable for 25% of the underlying shares on September 18, 2014, and thereafer becomes exercisable for the remaining underlying shares in equal monthly installments over three years, resulting in the option becoming exercisable for 100% of the underlying shares on the fourth anniversary of the date of grant.

Documents

2 files